CGS vs SPL

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

CGS

COGSTATE FPO [CGS]

57MEDIUM

SPL

STARPHARMA FPO [SPL]

56MEDIUM

Score Breakdown

CGS SPL
Technical
61
58
Catalyst
55
68
Sentiment
50
50
Fundamental
99
58
Momentum
64
63
Risk Gate
45
50

Key Metrics

CGS Metric SPL
$523.4MMarket Cap$345.9M
699KAvg Volume (20d)2.9M
+0.0%Short Interest+0.0%
$3.23052-Week High$0.815
$1.69052-Week Low$0.110
-0.3%Daily Change+2.1%
$3.070Reference Price$0.735
+22.5%ROE-45.6%
+19.5%Profit Margin-58.9%

Active Signals

CGS Signals

●Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (8.6x)
●Moderate revenue growth (+16%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week high (90% of range)

SPL Signals

●Stochastic just turned bullish from a low level — early reversal sign
●Death cross triggered — the short-term trend just crossed below the long-term, which is a bearish signal
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (14 quarters)
●Revenue in sharp decline (-56%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare CGS and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AHC vs NOX →ARX vs CGS →ATX vs CGS →AVE vs EYE →BLS vs CGS →
CGS Full Analysis → SPL Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).